Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes

Clinical trial NCT00190502 · UNKNOWN

Trial details

NCT number: NCT00190502
Sponsor: Institute for Clinical and Experimental Medicine
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2000-11-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.